Literature DB >> 22207559

Analysis of pituitary gonadotropin concentration in blood serum and immunolocalization and immunoexpression of follicle stimulating hormone and luteinising hormone receptors in ovaries of postmenopausal women.

A Brodowska1, M Laszczyńska, J Brodowski, M Masiuk, A Starczewski.   

Abstract

The participation of gonadotropins in ovarian carcinogenesis is well known and is supported by studies with inhibition of pituitary gonadotropin secretion, which results in a diminished risk of cancer. However, there are few data on localization and expression of Follicle Stimulating Hormone and Luteinising Hormone Receptors (FSHR and LHR) in ovaries of healthy postmenopausal women, and their correlation with FSH and LH concentration in blood serum is unknown. The aim of our study was to analyze gonadotropin concentration in blood serum and the expression of FSHR and LHR in ovaries of 207 postmenopausal women. Patients included in the study were divided into three groups depending on the number of years since menopause. We analyzed the concentration of FSH and LH in blood serum and the expression of FSHR and LHR in ovaries. Ovaries of postmenopausal women showed numerous morphological changes in the cortex and medulla when compared to the structure of ovaries of women at reproductive age. In all groups of patients clefts in the surface epithelium and epithelial inclusion cysts were found. The concentration of FSH and LH in the blood serum of women studied increased significantly with time from menopause. Significant differences between analyzed menopausal groups were found. The highest FSH and LH concentration in blood serum were found in women with the longest period of time from menopause. Quantitatively similar expression of FSHR and LHR was found in ovarian surface epithelial cells, in epithelial inclusion cysts and in the connective tissue cells of ovarian stroma. The intensity of the immunohistochemical reaction decreased with time from menopause and with age.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22207559     DOI: 10.14670/HH-27.241

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

1.  Luteinizing hormone inhibits cisplatin-induced apoptosis in human epithelial ovarian cancer cells.

Authors:  Lingfang Xia; Hao Wen; Xiaotian Han; Jia Tang; Yan Huang
Journal:  Oncol Lett       Date:  2016-01-18       Impact factor: 2.967

2.  Immunoexpression of aromatase cytochrome P450 and 17β-hydroxysteroid dehydrogenase in women's ovaries after menopause.

Authors:  Agnieszka Brodowska; Jacek Brodowski; Maria Laszczyńska; Sylwia Słuczanowska-Głąbowska; Bogdan Rumianowski; Iwona Rotter; Andrzej Starczewski; Mariusz Z Ratajczak
Journal:  J Ovarian Res       Date:  2014-05-10       Impact factor: 4.234

3.  Analysis of the Relationship between Estradiol and Follicle-Stimulating Hormone Concentrations and Polymorphisms of Apolipoprotein E and LeptinGenes in Women Post-Menopause.

Authors:  Aleksandra Rył; Andrzej Jasiewicz; Anna Grzywacz; Grażyna Adler; Karolina Skonieczna-Żydecka; Iwona Rotter; Olimpia Sipak-Szmigiel; Bogdan Rumianowski; Beata Karakiewicz; Anna Jurczak; Miłosz Parczewski; Anna Urbańska; Marta Grabowska; Maria Laszczyńska
Journal:  Int J Environ Res Public Health       Date:  2016-05-28       Impact factor: 3.390

4.  Parity-Dependent Hemosiderin and Lipofuscin Accumulation in the Reproductively Aged Mouse Ovary.

Authors:  Ulises Urzua; Carlos Chacon; Renato Espinoza; Sebastián Martínez; Nicole Hernandez
Journal:  Anal Cell Pathol (Amst)       Date:  2018-03-15       Impact factor: 2.916

5.  The Ovarian Transcriptome of Reproductively Aged Multiparous Mice: Candidate Genes for Ovarian Cancer Protection.

Authors:  Ulises Urzúa; Carlos Chacón; Maximiliano Norambuena; Luis Lizama; Sebastián Sarmiento; Esther Asaki; John I Powell; Sandra Ampuero
Journal:  Biomolecules       Date:  2020-01-09

Review 6.  The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis.

Authors:  Megan M Emori; Ronny Drapkin
Journal:  Reprod Biol Endocrinol       Date:  2014-07-06       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.